We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
+33.1%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$103M
AUM Growth
+$13M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$33M 32.13%
1,806,832
– –
OCUL icon
2
Ocular Therapeutix
OCUL
$2.19B
$18.5M 18.05%
2,215,384
– –
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
$18.1M 17.61%
407,416
– –
AKAO
4
DELISTED
Achaogen Inc
AKAO
$16.7M 16.24%
1,281,152
– –
IMDZ
5
DELISTED
Immune Design Corp.
IMDZ
$12.1M 11.82%
2,208,210
– –
GKOS icon
6
Glaukos
GKOS
$9.66B
$2.45M 2.38%
71,428
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$1.81M 1.77%
1,048,601
– –

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q4 2016 Portfolio in Review

As of Q4 2016, Versant Venture Management held 7 positions worth $103M, up 15% from $89.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's ten largest holdings make up 100% of its $103M portfolio in Q4 2016.
  • Versant Venture Management opened 0 new positions and closed 0 in Q4 2016.
  • Versant Venture Management's portfolio value rose 15% quarter-over-quarter to $103M.

Based on Versant Venture Management's 13F filing for Q4 2016, filed 18 Jan 2017.